Folliculotropic Mycosis Fungoides in 20 Korean Cases: Clinical and Histopathologic Features and Response to Ultraviolet A-1 and/or Photodynamic Therapy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Folliculotropic mycosis fungoides (FMF) is a variant of mycosis fungoides (MF) that is characterized clinically by variable types of skin eruptions, including plaques, acneiform lesions, and alopecic patches. Histopathologically, FMF is characterized by folliculotropic infiltrates. Objective: This study was conducted to scrutinize the clinical and histopathologic features of FMF in Koreans and the responses to phototherapy. Methods: Twenty Koreans diagnosed with MF who had histopathologic evidence of folliculotropism were enrolled. Results: Eighteen patients had head-and-neck-region infiltration, while five had solitary lesion. In all patients, the atypical lymphocytic infiltrate had a perifollicular distribution. Twelve patients were treated with ultraviolet A (UVA)-1. Eleven of these 12 patients with early-stage FMF experienced ＞80% improvement (8: complete remission; 3: partial remission). Four patients, including 2 who relapsed after UVA-1, were treated with photodynamic therapy (PDT), reaching complete remission after PDT. Conclusion: As FMF has variable clinical presentations, skin biopsy is required to confirm the diagnosis. And both UVA-1 and methyl aminolevulinate-PDT are clinically effective in treatment of early-stage FMF.
Abstract
Background: Folliculotropic mycosis fungoides (FMF) is a variant of mycosis fungoides (MF) that is characterized clinically by variable types of skin eruptions, including plaques, acneiform lesions, and alopecic patches. Histopathologically, FMF is characterized by folliculotropic infiltrates. Objective: This study was conducted to scrutinize the clinical and histopathologic features of FMF in Koreans and the responses to phototherapy. Methods: Twenty Koreans diagnosed with MF who had histopathologic evidence of folliculotropism were enrolled. Results: Eighteen patients had head-and-neck-region infiltration, while five had solitary lesion. In all patients, the atypical lymphocytic infiltrate had a perifollicular distribution. Twelve patients were treated with ultraviolet A (UVA)-1. Eleven of these 12 patients with early-stage FMF experienced ＞80% improvement (8: complete remission; 3: partial remission). Four patients, including 2 who relapsed after UVA-1, were treated with photodynamic therapy (PDT), reaching complete remission after PDT. Conclusion: As FMF has variable clinical presentations, skin biopsy is required to confirm the diagnosis. And both UVA-1 and methyl aminolevulinate-PDT are clinically effective in treatment of early-stage FMF.
참고문헌 (27)
- Kazakov DV, "Clinicopathological spectrum of mycosis fungoides", J Eur Acad Dermatol Venereol, 18, pp.397~415 (2004)[DOI]
- van Doorn R, "Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients", Arch Dermatol, 136, pp.504~510 (2000)
- 장민수, "Pityriasis Lichenoides-like Mycosis Fungoides: Clinical and Histologic Features and Response to Phototherapy", Annals of Dermatology, 28(5), pp.540~547 (2016), 대한피부과학회
- Muniesa C, "Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases", J Am Acad Dermatol, 62, pp.418~426 (2010)[DOI]
- Aydogan K, "Efficacy of low-dose ultraviolet a-1 phototherapy for parapsoriasis", early-stage mycosis fungoides, 2014, pp.90, 873~877
- Lehman JS, "Folliculotropic mycosis fungoides: single-center study and systematic review", Arch Dermatol, 146, pp.607~613 (2010)
- Gerami P, "Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma", Arch Dermatol, 144, pp.738~746 (2008)
- van Doorn R, "Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients", Arch Dermatol, 138, pp.191~198 (2002)
- Gerami P, "The spectrum of histopathologic and immunohistochemical findings in folliculotropic mycosis fungoides", Am J Surg Pathol, 31, pp.1430~1438 (2007)[DOI]
- Amitay-Laish I, "Unilesional folliculotropic mycosis fungoides: a unique variant of cutaneous lymphoma", J Eur Acad Dermatol Venereol, 30, pp.25~29 (2016)
- Cerroni L, "Skin lymphoma: the illustrated guide. 4th ed." (2014), Wiley-Blackwell
- Jang MS, "Clinicopathological manifestations of ichthyosiform mycosis fungoides", Acta Derm Venereol, 96, pp.100~101 (2016)[DOI]
- Hur J, "Mycosis fungoides presenting as Ofuji's papuloerythroderma", J Eur Acad Dermatol Venereol, 16, pp.393~396 (2002)[DOI]
- Jang MS, "CD25+ folliculotropic Sezary syndrome with CD30+ large cell transformation", Australas J Dermatol, 55, pp.e4~e8 (2014)[DOI]
- Oppen K, "Incidental findings of monoclonal proteins from carbohydrate-deficient transferrin analysis using capillary electrophoresis", Clin Chem Lab Med, 55, pp.e133~e136 (2017)
- Agar NS, "Survival outcomes and prognostic factors in mycosis fungoides", Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas, J Clin Oncol, pp.2010, 28[DOI]
- Benner MF, "Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases", Blood, 119, pp.1643~1649 (2012)[DOI]
- van Santen S, "Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides", JAMA Dermatol, 152, pp.992~1000 (2016)[DOI]
- Klemke CD, "Follicular mycosis fungoides", Br J Dermatol, 141, pp.137~140 (1999)[DOI]
- Breuckmann F, "Mechanisms of apoptosis: UVA1-induced immediate and UVB-induced delayed apoptosis in human T cells in vitro", J Eur Acad Dermatol Venereol, 17, pp.418~429 (2003)[DOI]
- Weichenthal M, "Phototherapy: how does UV work?", Photodermatol Photoimmunol Photomed, 21, pp.260~266 (2005)[DOI]
- Tewari A, "UVA1 is skin deep: molecular and clinical implications", Photochem Photobiol Sci, 12, pp.95~103 (2013)[DOI]
- Yamauchi R, "Different susceptibility of malignant versus nonmalignant human T cells toward ultraviolet A-1 radiation-induced apoptosis", J Invest Dermatol, 122, pp.477~483 (2004)[DOI]
- Olek-Hrab K, "Ultraviolet A1 phototherapy for mycosis fungoides", Clin Exp Dermatol, 38, pp.126~130 (2013)[DOI]
- Kim ST, "Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides", Acta Derm Venereol, 92, pp.264~268 (2012)[DOI]
- Debu A, "Photodynamic therapy with methyl aminolaevulinate for cervical and", or facial lesions of folliculotropic mycosis fungoides: interest and limits, 2013, pp.168, 896~898
- Wiegell SR, "Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate", J Am Acad Dermatol, 54, pp.647~651 (2006)[DOI]